Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure.

ABSTRACT:

SUBMITTER: Simpson EL 

PROVIDER: S-EPMC11193687 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature